Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for confetti-like macular atrophy.
3 publications have been identified in PubMed for confetti-like macular atrophy. Research spans Review / Meta-Analysis (100%).
Pálla S (2026). [PMID: 41165034](https://pubmed.ncbi.nlm.nih.gov/41165034/). *Int J Dermatol*. [Review / Meta-Analysis]
Lozano LP (2025). [PMID: 40274012](https://pubmed.ncbi.nlm.nih.gov/40274012/). *Prog Retin Eye Res*. [Review / Meta-Analysis]
Ettinger M (2025). [PMID: 39606894](https://pubmed.ncbi.nlm.nih.gov/39606894/). *J Eur Acad Dermatol Venereol*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 12:50 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about confetti-like macular atrophy